Omnitrope
Payments companies reported to CMS as associated with Omnitrope. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Omnitrope, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Omnitrope
These are the largest totals companies reported as associated with Omnitrope. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Amy Burton | Plano, TX | Pediatric Endocrinology | $109.12 |
| Kathryn Springfield | Plano, TX | Physician Assistant | $109.11 |
| Marines Castillo Echevarria | West Palm Beach, FL | Pediatric Endocrinology | $59.36 |
| Vickie Wu | New York, NY | Pediatrics | $58.36 |
| Natinder Saini | Norfolk, VA | Pediatric Endocrinology | $56.67 |
| Eric Gyuricsko | Norfolk, VA | Pediatric Endocrinology | $56.66 |
| Jorge Serrat | Pembroke Pines, FL | Pediatric Endocrinology | $51.60 |
| Elizabeth Burtman | Tenafly, NJ | Pediatric Endocrinology | $50.15 |
| Middey Damian | Wellington, FL | Pediatric Endocrinology | $47.30 |
| Robert Fredericks | Reno, NV | Endocrinology, Diabetes & Metabolism | $34.70 |
Prescribed Omnitrope?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.